NEUROONE MEDICAL TECHNOLOGIES Corp
NMTCNasdaqCIK 1500198HealthcareFiscal year ends Sep 30
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-1420:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-042948 |
| 2024-05-1420:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-042938 |
| 2024-03-2613:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-025811 |
| 2024-03-1520:30 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-023083 |
| 2024-02-1321:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-013294 |
| 2024-02-1321:05 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001213900-24-013276 |
| 2024-01-2914:00 ET | DEF 14A | Proxy statementPeriod 2024-03-14 | 0001213900-24-007191 |
| 2023-12-1521:39 ET | 10-K | Annual reportPeriod 2023-09-30 | 0001213900-23-096120 |
| 2023-12-1421:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-095741 |
| 2023-12-1113:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-094562 |
| 2023-11-1613:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-087723 |
| 2023-11-1422:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-087126 |
| 2023-11-0713:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-084013 |
| 2023-08-1420:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-067061 |
| 2023-08-1420:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-067019 |
| 2023-07-2720:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-060256 |
| 2023-05-1220:15 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-039030 |
| 2023-05-1120:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-038538 |
| 2023-03-1720:34 ET | 8-K | 5.07 Shareholder vote results | 0001213900-23-021037 |
| 2023-03-1022:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-23-019237 |
| 2023-02-1421:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-011512 |
| 2023-02-1321:15 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001213900-23-010739 |
| 2023-01-2713:30 ET | DEF 14A | Proxy statementPeriod 2023-03-16 | 0001213900-23-005481 |
| 2023-01-1321:15 ET | 8-K | 8.01 Other events | 0001213900-23-002798 |
| 2022-12-2214:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-081976 |
| 2022-12-2201:52 ET | 10-K | Annual reportPeriod 2022-09-30 | 0001213900-22-081897 |
| 2022-12-1621:16 ET | 8-K | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001213900-22-080515 |
| 2022-10-2513:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-065984 |
| 2022-09-1412:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-055776 |
| 2022-08-1120:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-046936 |
| 2022-08-1120:30 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-046902 |
| 2022-08-0313:34 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-044311 |
| 2022-06-0220:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-030944 |
| 2022-05-3120:31 ET | 10-K/A | Annual report, amendedPeriod 2021-09-30 | 0001213900-22-030420 |
| 2022-05-1620:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-027182 |
| 2022-05-1220:26 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-025966 |
| 2022-05-1220:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-025953 |
| 2022-04-2912:00 ET | DEF 14A | Proxy statementPeriod 2022-05-31 | 0001213900-22-022526 |
| 2022-03-2520:45 ET | 8-K | 8.01 Other events | 0001213900-22-015203 |
| 2022-02-1421:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-007517 |
| 2022-02-1421:02 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001213900-22-007486 |
| 2022-02-0421:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-22-005501 |
| 2021-12-1521:31 ET | 10-K | Annual reportPeriod 2021-09-30 | 0001213900-21-065463 |
| 2021-12-1513:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-065344 |
| 2021-10-1413:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-052752 |
| 2021-10-0420:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-21-000094 |
| 2021-09-0720:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-046892 |
| 2021-08-1312:15 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-042294 |
| 2021-08-1312:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-042291 |
| 2021-06-2420:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-21-033970 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.